Digital Biomarkers

Digital biomarkers are changing the face of clinical trials. By allowing for the collection of high-density data from wearables and apps, we can gain new, more powerful insights into the ability of novel therapeutics to modulate or modify disease. Biospective has performed multiple digital biomarker studies for its sponsors, and we have implemented processes for the acquisition, quality control, and analysis of this “Big Data”.

Validation of Novel Digital Health TechnologiesValidation of Novel Digital Health Technologies

REB Submissions


Data and Project Management


Deployment of Digital Biomarkers in Multicenter Clinical Trials


Subject Recruitment 

Statistical Analysis


Study Protocol Design


Functional Assessments


Final Report